NCT02236871

Brief Summary

The final stages in the development of peak bone mass (PBM) reside in late adolescence or early adulthood and are critical in the achievement of bone health. Optimization of PBM and maintenance of bone mineral density (BMD) are the best population health strategies in the primary prevention of osteoporosis. Diet and activity are key lifestyle factors in the primary prevention of osteoporosis as recognized in Canada's Food and Activity Guides. Dietary Reference Intakes are evidence-based regarding nutrition and bone health with a focus on calcium and vitamin D; yet the Food Guide and health behaviors are reliant on actual foods. The number of recommended servings of milk and alternatives varies by age with average intakes estimated to be below targets for all Canadians \> 9 y of age. This is especially concerning during development of PBM. Therefore, the global objective is to generate high-level evidence that dietary intervention with milk and milk products will enhance PBM in young men and women and maintenance of BMD in their parents. The primary objective is to demonstrate in healthy young men and women (14-18.9 y at baseline) with habitually low usual milk and milk product intakes that intervention with greater milk and milk product consumption improves lumbar spine BMD in a dose-response manner over 2 y (while accounting for body size, physical activity, demographics and age). Healthy young men and women will be recruited and screened for usual intake of milk and milk products. Those with low intakes \< 2 servings of milk or milk products will be randomized (stratified by sex and age) to 1 of 3 groups for the RCT (n=10090/group): maintain usual low intakes (\<1 serving), improved intakes (average of 2 servings/d) or recommended intakes (≥3 servings/d) of milk and milk products. A manualized motivational interviewing framework will be used for the interventions. Those meeting recommendations at screening will form a longitudinal cohort for 2 y. Key measurements include baseline and yearly assessment of BMD at multiple sites plus interim assessment of general health, anthropometry, dietary intakes, physical activity and biomarkers of calcium homeostasis; and in the young adults bone metabolism.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 4, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 11, 2014

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

February 5, 2020

Status Verified

February 1, 2020

Enrollment Period

5.6 years

First QC Date

September 4, 2014

Last Update Submit

February 4, 2020

Conditions

Keywords

AdolescentsDairyBone

Outcome Measures

Primary Outcomes (1)

  • Change in lumbar spine BMD (g/cm2) at 2 years.

    To examine in healthy young men and women (14-18.9 y at baseline) with habitually low usual milk and milk product intakes (\<1 serving/d) whether intervention with greater milk and milk product consumption improves lumbar spine (LS) BMD at 2 years in a dose-response manner.

    up to 2 years

Secondary Outcomes (5)

  • Change in calcium homeostasis at 2 years.

    up to 2 years

  • Change in whole body BMD (g/cm2) at 2 years

    up to 2 years

  • Change in total hip BMD (g/cm2) at 2 years.

    up to 2 years

  • Change in distal forearm BMD (g/cm2) at 2 years.

    up to 2 years

  • Change in femoral neck BMD (g/cm2) at 2 years.

    up to 2 years

Study Arms (3)

Control

NO INTERVENTION

Maintain current milk and milk product intakes.

2 servings

ACTIVE COMPARATOR

Participants will be asked to consume 1 milk (250 ml) plus a yogurt (100-175 g) or cheese (up to 50 g) to reach an average of 2 servings of milk or milk products/d.

Behavioral: 2 servings

4 servings

ACTIVE COMPARATOR

Participants will be asked to consume recommended servings of milk or milk products/d for their age, so they will receive 1 milk (250 ml), a yogurt (175 g) and cheese (50 g) or more. This would provide ≥ 3 servings/d.

Behavioral: 4 servings

Interventions

2 servingsBEHAVIORAL

Participants will receive motivational counseling to help the improve milk and milk product intakes to 2 servings per day.

2 servings
4 servingsBEHAVIORAL

Participants will receive motivational counseling to help them increase their milk and milk product intake to 4 servings per day.

4 servings

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • to 18.9 y of age at onset of the intervention
  • reside with their parents
  • consume \< 1 serving/d of milk and milk products
  • \> 2 y post-menarche
  • non smoker
  • not routinely taking prescribed oral medication including oral/dermal
  • healthy body mass index (BMI) defined as ± 1SD of 50% percentile WHO curves
  • normal bone mass for age/sex
  • adequate vitamin D status (\>30 nmol/L 25(OH)D)
  • no anemia
  • receptive to stop any nutritional supplements 2 weeks prior to and during the study.

You may not qualify if:

  • Any known chronic disease with exception of mild asthma (\<500 µg budesonide) that does not affect BMD Z-scores
  • Anaemic (defined as Hg \<13.5 g/dL in males and \<12.0 g/dL in females for their age group).
  • Known allergies or aversions to milk and milk products
  • Anticipating becoming pregnant or a moving distant from Montreal or from family home in the next 2 y.
  • Have preference for non-dairy alternatives
  • consume ≥2 alcoholic beverages/day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mary Emily Clinical Nutrition Research Unit

Sainte-Anne-de-Bellevue, Quebec, H9X2E3, Canada

Location

Related Links

Study Officials

  • Hope A Weiler, PhD

    McGill University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 4, 2014

First Posted

September 11, 2014

Study Start

May 1, 2014

Primary Completion

December 20, 2019

Study Completion

December 20, 2019

Last Updated

February 5, 2020

Record last verified: 2020-02

Locations